Recently, Rumnieks and Tars (2012) surveyed the few available ssRNA phage genomes (Fig. 1a) and found that lysis genes appear to have evolved at different sites after speciation of the phage to infect cells with new pili receptors 5 . In particular, levivirus M has its lys M gene embedded in the + 1 reading frame of rep. We observed that expression of lys M from a multi-copy plasmid induced morphological defects prior to lysis that were similar to those caused by A 2 , E and beta-lactams, suggesting that Lys M might also inhibit PG biosynthesis (Fig. 1b,c and Supplementary Fig. 1 ). To identify its target, we introduced a multi-copy plasmid library containing random fragments of the E. coli genome to cells producing Lys M and selected for lysis-resistant clones. Three of the survivors contained plasmids carrying murJ ( Supplementary Fig. 2 Fig. 3 ). Further support for MurJ being the Lys M target came from the isolation of spontaneous mutants in murJ promoting resistance to lys M expression ( Fig. 1d and Supplementary Fig. 4a,b) .
. However, FtsW has not been found to be critical for lipid II translocation in vivo 6 . MurJ, on the other hand, has been shown to be essential for PG synthesis and lipid II flipping in vivo 6, 7 . Moreover, it is related to transporters implicated in translocating other lipid-linked polysaccharide precursors such as those for O-antigen synthesis 9 . Finally, chemical probing and a recently published crystal structure indicate that MurJ has a solvent-exposed cavity consistent with it functioning as a transporter 10,11. Amino-acid substitutions in MurJ resulting in Lys M -resistance cluster in two of its fourteen transmembrane domains (TMDs), TMD2 and TMD7, which form part of the solvent-exposed cavity ( Fig. 2 and Supplementary Table 2 ). None of these changes affected MurJ accumulation ( Supplementary Fig. 5 ). We used thiol accessibility (substituted-cysteine accessibility method (SCAM)) to address whether Lys M affected MurJ conformation in the membrane. Cysteine substitutions in ten positions in MurJ were tested for reactivity to the thiol reagents MTSES (sodium (2-sulfonatoethyl) methanethiosulfonate; membrane-impermeable) and NEM (N-ethylmaleimide; membrane-permeable) in cells producing Lys M -cmyc ( Fig. 3 and Supplementary Fig. 6 ). The SCAM reactivity patterns for five positions in aqueous domains were unaffected by lys M induction, but five TMD positions exhibited altered MTSES sensitivity, with four being converted from partial to complete reactivity. These results suggest that Lys M binds to MurJ and causes a conformational change that locks MurJ into one of the two conformations proposed to constitute the lipid II flipping cycle, with the solvent-filled cavity facing either the periplasm or cytoplasm [10] [11] [12] ( Supplementary Fig. 7 ). Accordingly, induction of lys M in cells overexpressing non-functional alleles of murJ that produce normal levels of protein 12 did not protect against Lys M -dependent lysis, whereas the wild-type allele does ( Supplementary Fig. 4d) .
To assess the effect of Lys M on MurJ-dependent lipid II flipping activity, we used a previously published in vivo flippase assay 6, 13 . In this assay, cells are radiolabelled with the PG precursor [ 3 H]mesodiaminopimelic acid (mDAP) and treated with colicin M (ColM), a toxin that invades the periplasm to cleave flipped lipid II, generating a soluble pyrophospho-disaccharide pentapeptide that is subsequently converted to disaccharide tetrapeptide by periplasmic carboxypeptidases. The other product is undecaprenol, a probably dead-end derivative of the lipid carrier that cannot be reused 6, 14 . Thus, ColM function blocks PG synthesis ( Supplementary Fig. 9 ), irreversibly removes radiolabel from the PG lipid precursor pool, and leads to the production of a new soluble radiolabelled product. Inactivation of MurJ function was previously shown to prevent lipid II cleavage by ColM by blocking lipid II translocation across the membrane, thus leading to the protection of the radiolabelled PG lipid precursor pool and the absence of the ColM Letters NATuRE MIcRobIoLoGY soluble product 6 . Lys M production similarly blocked depletion of the PG lipid precursor pool by ColM (Fig. 4a and Supplementary  Fig. 10 
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overproduction of the unrelated (alternative) lipid II flippase Amj from Bacillus subtilis 13 also promoted resistance to Lys M production ( Supplementary Fig. 11 ). We therefore conclude that the phage M lysis gene is likely to encode a specific inhibitor of MurJ that blocks lipid II flipping. Although direct binding of Lys M to MurJ remains to be demonstrated, Lys M clearly joins the E and A 2 proteins as the third instance of a 'protein antibiotic' targeting an essential step of PG biosynthesis.
The φ X174 E protein inhibits MraY 15 and is encoded in the + 1 reading frame of an essential morphogenesis gene (Fig. 1a) . Maturation proteins are present as a single molecule on the capsid of all leviviruses 16 , serving to recognize and bind to the F pilus. However, in Qβ , the maturation protein A 2 has evolved an additional ability to inhibit MurA 4 . Like these factors, lys M occupies no dedicated genetic space 5 , highlighting the ability of small phages to maximize their coding capacity. Recent analysis of publicly available metagenomes and transcriptomes has revealed that the ssRNA leviviruses are more ubiquitous and diverse than previously appreciated 17, 18 , at least in part because of extensive use of RNase during virome sampling. RNA phages are therefore estimated to constitute a substantial fraction of the total virome in gut samples 19 , representing a deep resource of genomic 'dark matter' . Our results suggest that leviviruses, empowered by the error-prone character of their RNA replicase 20, 21 and economic use of genomic space, are capable of generating a vast environmental library of small proteins that can block a variety of steps in PG synthesis. The genetics of ssRNA phages may thus turn out to be powerful tools for identifying targetable sites in cell wall biogenesis enzymes to aid the development of new antibiotics.
Methods
Bacterial strains, plasmids and growth conditions. The bacterial strains and plasmids used in this study are listed in Supplementary Table 3 . Primers are listed in Supplementary Table 4 . Cultures were grown with aeration at 37 °C in lysogeny broth (LB) supplemented with ampicillin (100 μ g ml
), chloramphenicol (10 or 25 μ g ml
) and l-arabinose (0.4% w/v), when indicated isopropyl-β -d- The substitutedcysteine accessibility method (SCAM) was used to determine whether the production of Lys M changes the conformation of MurJ in the inner membrane (IM). Conformational changes were reflected as changes in the exposure of cysteine residues introduced at specific positions in MurJ (indicated on the left) to the aqueous periplasm or cytoplasm by comparing SCAM results from samples with or without Lys M production as indicated. Immunoblotting was used to monitor the mass shift in MurJ-FLAG that the thiol-modifying agent Mal-PEG causes unless cysteines were previously modified by IM-permeable NEM (reacts with cysteines exposed to either the periplasm or the cytoplasm) or IM-impermeable MTSES (reacts only with periplasmic cysteines). Substitutions in green showed no change in SCAM pattern; substitutions in pink showed less modification by MTSES and NEM (and therefore more Mal-PEG modification), indicating less exposure to the aqueous environment; and substitutions in red showed more modification by MTSES and NEM (and therefore less Mal-PEG modification), indicating more exposure to the aqueous environment. See Supplementary Fig. 6 for more details. Shown are the representative blots from three biological replicates. Supplementary Fig. 10 . cpm, counts per minute; cps, counts per second. ***p< 0.001; **p< 0.01; NS, not significant.
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thiogalactopyranoside (IPTG; RPI) at 25 μ M or 50 μ M final concentration was added, and 20 μ g ml −1 final 5-bromo-4-chloro-indolyl-β -D-galactopyranoside (X-Gal) when indicated. All chemicals were supplied by Sigma Aldrich unless otherwise indicated. The Δ pyrC::kan allele was obtained from Keio collection 22 and was transduced into appropriate strains by P1 transduction 23 . Plasmid pKC3 (bla araC P ara ::lys-his 6 lacZα) encoding a hexahistidine-tagged Lys M was constructed in multiple steps. First, a synthetic construct was obtained (GenScript) containing the DNA sequence from phage M (accession number: JX625144) encompassing the lys gene and lacZα, flanked by restriction sites for EcoRI and XhoI/HindIII upstream and downstream, respectively, to facilitate cloning, and with its start codon changed from TTG to ATG. This lys construct was sub-cloned into pBAD24 between the EcoRI and HindIII sites to yield pKC1. Codons encoding a hexa-histidine tag were inserted at the 3' end of lys in pKC1 through site-directed mutagenesis with the primer KC163, to generate pKC2. The resulting lys-his6 gene was amplified from pKC2 by PCR with primers KC30 and KC210 and Pfu DNA polymerase. The PCR product was digested with EcoRI and XhoI and cloned between the corresponding sites in pKC1 to yield pKC3. The cloned fragments at each step were verified by sequencing.
A lys gene modified at its 3' end with codons for the cmyc tag (GEQKLISEEDLNSAVD) was obtained as part of a gBlock (IDT) containing flanking KpnI and HindIII sites. Plasmid pKC4 (bla araC p ara ::lys-cmyc) was constructed by digesting the gBlock with KpnI and HindIII and ligating the product into the corresponding sites in the vector pBAD30.
The plasmid pKC5 (cat araC p ara ::lys-cmyc) was constructed by sub-cloning lys-cmyc from pKC4 to pBAD33 with KpnI and HindIII.
The plasmid pKC6 (bla araC p ara ::lysC10S-cmyc) was constructed in a similar way to pKC4 where the codon for cysteine at position 10 was changed to serine.
The plasmid pKC7 (bla araC p ara ::lys-eGFP) was constructed by cloning of lys-eGFP gBlock into pBAD30 vector digested with KpnI and HindIII.
The plasmid pKC8 (cat araC p ara ::murJ-eGFPΩ kan) was constructed in multiple steps. First, the kan cassette was amplified from the pKD4 plasmid using the primers KC273 and KC274. The resulting PCR product was used as a primer for site-directed mutagenesis to introduce the kan marker downstream of the murJ gene in the multi-copy suppressor plasmid no. 2 (Supplementary Table 1) . A second round of site-directed mutagenesis was performed to fuse eGFP in frame with murJ. The eGFP gene was amplified from the pKC7 plasmid using the primers KC328 and KC329.
Mutant alleles of murJ were constructed by site-directed mutagenesis into the plasmid pFLAGMurJΔ Cys 10 using Phusion high-fidelity DNA polymerase (New England Biolabs) and the primers KC238, KC247, KC248, KC249, KC252, KC253, KC254, KC263 and KC264.
Strains RY34351, RY34352, RY34363, RY34366, RY34376, RY34380 and RY34381 carrying Lys ). The murJ loci from transductants were amplified by PCR with the primers KC230 and KC234 and the mutations were confirmed by sequencing. Strain RY34432 was constructed by recombineering the murJ-e GFPΩkan PCR fragment, amplified from pKC8 using the primers KC231 and KC234, into the TB28 strain and the resulting recombinants were selected for kanamycin resistance. The murJ-eGFPΩkan recombinants were transduced into a clean background (TB28) using P1 transduction. PCR analysis was used to verify the construct at each step of the process.
Multi-copy suppression. The E. coli multi-copy library containing 1-4-kb fragments of chromosomal DNA under p ara control used in this study was constructed for an earlier work 24 . Approximately 200 ng of pooled multi-copy library and ~100 ng of pKC3 plasmid were co-transformed into XL1-Blue by electroporation. The transformants were plated on LB-Ara-Amp-IPTG-X-gal plates to select and screen for survivors. The blue colonies that appeared on the selection plates were picked and the plasmid DNA was extracted using a Qiagen mini-prep kit. The extracted DNA was digested with HindIII and analysed on 0.8% agarose for 1 h at 95 V to separate pKC3 from the multi-copy library plasmid. The slower migrating band was gel-purified using a Qiagen gel-extraction kit, self-ligated, transformed into XL1-Blue, and selected on LB-chloramphenicol (10 μ g ml ) plates. The plasmid DNA was extracted with Qiagen mini-prep kit and the junctions were sequenced at Eton Bioscience Inc. with the primers KC30 and KC31. The sequence of the inserts was mapped to the E. coli MG1655 genome (NC_000913.3) to identify the possible suppressors. To rule out the suppressors that interfere with arabinose uptake and utilization, the isolates were streaked on M9 minimal agar with arabinose (0.2% w/v) as the sole carbon source.
Selection and screening for Lys
M -resistant mutants. Cultures of XL1-Blue pKC3 were grown to A 550 nm~0 .2 and lys M was induced with arabinose (0.4% w/v). At ~2 h post-induction, cells were collected from 10 ml of culture through centrifugation at 6,000g for 10 min, resuspended in 100 μ l LB, and plated on LB-Ara-Amp-IPTG-X-gal plates. The colonies that turned blue after overnight incubation at 37 °C were picked and streak-purified on the same selection media. The Lys in Lys M -resistant mutants were compared with that in the wild type by western blotting with anti-His (Sigma-Aldrich). The murJ locus in Lys M -resistant mutants was amplified by PCR using Phusion high-fidelity DNA polymerase (New England Biolabs) with the primers KC230 and KC234. The amplified PCR product was gelpurified and sequenced with the primers KC230, KC231, KC234 and KC262.
Microscopy. Strain TB28 pKC3 was grown to A 550 nm~0 .2 and induced with l-arabinose 0.4% (w/v). At 20 min post-induction, 1 ml of culture was spun down at 14,000g for 30 s. The pellet was resuspended in 20 μ l, of which 5 μ l was spotted on a glass slide with a coverslip on top. Phase-contrast images of the cells were taken with a Zeiss AX10 microscope with × 100 oil immersion objective and 100 ms exposure.
Plasmid retention assay. TB28 cells carrying plasmids with different mutant alleles of murJ were grown to A 550 nm~0 .2 and induced with 0.4% arabinose. The cell lysates 1 h post-induction were harvested, filter sterilized, and passed through Qiagen DNA binding columns. The bound DNA was eluted with water and transformed into TB28 and the number of transformants was counted. The murJ alleles that gave the least number of transformants were scored as tight mutants.
Detecting lipid II flippase activity with ColM. Lipid II flippase assays were done with slight modifications from previously described 6 . Strain RY34351/pKC4, TU276/pFLAGMurJ/pKC4 and TU276/pFLAGMurJ M233L, I248S /pKC4 were grown in LB supplemented with 0.2% (w/v) glucose, 25 µ g ml −1 of chloramphenicol and 15 µ g ml −1 ampicillin at 37 °C with shaking overnight. Cultures were then diluted 1:100 into M9 medium supplemented with 0.2% maltose and 100 µ g of methionine, lysine and threonine and incubated at 37 °C with shaking. When A 600 nm~0 .3, 15 µ l of [ 3 H]mDAP (1µ Ci µ l −1 , ARC) was added to 10 ml of culture and arabinose was added to a final concentration of 0.4% (w/v) as indicated. After 15 minutes, 10 µ l of colicin M (500 µ g ml −1 ) was then added to the culture. Cells were grown for an additional 10 min, immediately chilled on ice, and then harvested by centrifugation at 10,000g for 2 min at 4 °C. Spent supernatant was discarded carefully, and cell pellets were resuspended in 1 ml of hot water and further incubated at 100 °C for 30 min. Heat-killed cells (containing labelled lipid intermediates and labelled cell wall) and hot-water extracts (containing soluble labelled PG precursors and ColM product) were separated by centrifugation at 100,000g for 20 min at 4 °C. The supernatant fractions containing soluble material were lyophilized, dissolved in 300 µ l of buffer A (50 mM triethylammonium formate pH 4.6, 6% (v/v) methanol), followed by HPLC with 70 min isocratic elution of buffer A on a Nucleosil C18 column (Agilent A0119250× 046). Radiolabelled soluble PG precursors and ColM products in the eluate were detected by an inline radioflow detector (Berthold). The hot-water-extracted cell pellets were boiled for 3 min in 1 ml of water to remove residual water-soluble radiolabelled compounds. The washed pellets were then resuspended in 100 µ l of 10 mM Tris-HCl pH 7.4. Lipid-linked precursors were extracted from the pellet suspension twice by adding 100 µ l of 6 M pyridinium acetate/1-butanol (1:2, v/v) followed by vortexing. The top butanol fractions were carefully transferred to a new tube after centrifugation at 3,000g for 30 s and washed once with 100 µ l butanol-saturated water. Labelled lipid-linked precursors were then quantified from 100 µ l of the butanol fractions (top) by scintillation counting in 10 ml of Ecolite scintillation fluid (882745, MP Biochemicals).
Note that because the radiolabelled soluble compounds were measured using the inline radioflow detector and the lipid intermediates by scintillation counting, the units of radioactivity for quantifying these species are different. Given that the trend of the measurements was clear and consistent (that is, when lipid precursors increased, soluble ColM products decreased and vice versa), we did not think that calibration of the different instruments was necessary.
Measurement of PG synthesis following ColM treatment. Strain TU276/ pFLAGMurJ/pKC4 was grown in LB medium supplemented with 0.2% (w/v) glucose, 25 µ g ml −1 of chloramphenicol and 15 µ g ml −1 ampicillin at 37 °C with shaking overnight. Cultures were then diluted 1:100 into 35 ml of M9 medium supplemented with 0.2% maltose and 100 µ g of methionine, lysine and threonine and incubated at 37 °C with shaking. When cultures reached an A 600 nm of ~ 0.3, 10 ml was transferred to a 50 ml conical tube and 15 µ l of [ , ARC) was added. Starting at 9 min after label addition, 1 ml samples were withdrawn every 3 min, measured for A 600 nm , and transferred to a 1.5 ml tube on ice. Following 15 min of labelling, ColM was added to a final concentration of 500 µ g ml to one of the cultures (t= 0 in Supplementary Fig. 9 ). Samples (1 ml) were then withdrawn every 2 min measured for A 600 nm , and chilled on ice. Incorporation of label into the PG fraction was performed essentially as previously described 25 . Briefly, samples were centrifuged at 10,000g for 1 min at 4 °C. Cell pellets were resuspended in 1 ml of hot water and further incubated at 100 °C for 30 min to extract labelled soluble PG precursors. Cells were then pelleted by centrifugation at 100,000g for 20 min at 4 °C, washed once with 1 ml of PG buffer (20 mM Tris-HCl pH 7.4, 25 mM NaCl) and resuspended in 0.5 ml of PG buffer. PG was digested by adding 0.25 mg lysozyme and incubated overnight at 37 °C. Insoluble material was pelleted by centrifugation at 20,000g for 20 min at room temperature and radioactivity released into the supernatant fraction by lysozyme (designated labelled PG) was measured by scintillation counting as described above.
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Quantification of the levels of MurJ and Lys M . Cultures (500 ml) of strains RY34159, RY34442 and RY34443 were grown to A 550 nm~0 .4 units and induced with 0.4% arabinose, the cells were collected 10 min post-induction by centrifugation for 10 min at 10,000 x g (Sorvall Lynx 6000 centrifuge), resuspended in ~4 ml 1× PBS, lysed by passing three times through an Amico French Pressure cell at 16,000 psi, and the cell lysates were cleared of intact cells by centrifugation for 10 min at 10,000g (Sorvall Legend XTR centrifuge). The cleared supernatants (~ 3 ml) were centrifuged at 100,000g (Beckman TL100 centrifuge) to collect membrane fractions, and the membrane fractions were then resuspended in 1 ml of 1× PBS. The membrane fractions from A 550 nm~4 .0 units, and purified eGFP standards (kindly provided by H. Rye) were mixed with 2× AB buffer (6.84 mM Na 2 HPO 4 , 3.16 mM NaH 2 PO 4 , 50 mM Tris-HCl pH 6.8, 6 M urea, 1% β -mercaptoethanol, 3% SDS, 10% glycerol, 0.1% bromophenol blue) and treated as previously described 10 . The samples were resolved on 4-20% Tris-tricine gel and western blotted with rabbit polyclonal anti-GFP (ab290 from Abcam) at 1:2,000 dilution and goat-anti-rabbit-HRP (ThermoFisher Scientific) at 1:3,000. The protein levels were quantified using ImageJ software.
Complementation test of pFLAGMurJΔCys derivatives. The ability of pFLAGMurJΔ Cys-derived plasmids to complement a chromosomal Δ murJ::frt allele was tested as previously described 14 using strain NR3267 (NR754 Δ murJ::frt pRC7KanMurJ) 9 . Haploid strains carrying complementing pFLAGMurJΔ Cys-derived plasmids and merodiploid strains NR3942 (NR754 pFLAGMurJΔ Cys V229G, I248S ) and its wild-type derivative NR2449 (NR754 pFLAGMurJΔ Cys V229G, I248S ) were processed for western blotting using anti-FLAG M2 (Sigma-Aldrich) and anti-mouse-HRP (GE Amersham). For immunoblots, cells were grown overnight, normalized by A 600 nm , pelleted and lysed with 50 µ l of SCAM lysis buffer (5 mM Tris-HCl pH 7.4, 1 % SDS, 6 M urea). Prior to loading onto a 10 % SDS-polyacrylamide gel, samples were mixed with 50 µ l of 2× AB buffer. Table 3 
SCAM. murJ haploid strains (Supplementary
Data exclusions
Describe any data exclusions. No data were excluded from the analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization is not relevant to this study because we studied the mode of action of a specific phage lysis protein.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding is not relevant to this study because we studied the mode of action of a specific phage lysis protein.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
